Quest Diagnostics Revenue 2010-2024 | DGX

Quest Diagnostics revenue for the twelve months ending September 30, 2024 was $9.539B, a 2.6% increase year-over-year.

  • Quest Diagnostics annual revenue for 2023 was $9.252B, a 6.38% decline from 2022.
  • Quest Diagnostics annual revenue for 2022 was $9.883B, a 8.39% decline from 2021.
  • Quest Diagnostics annual revenue for 2021 was $10.788B, a 14.32% increase from 2020.

Quest Diagnostics Revenue 2010-2024 | DGX

  • Quest Diagnostics annual revenue for 2023 was $9.252B, a 6.38% decline from 2022.
  • Quest Diagnostics annual revenue for 2022 was $9.883B, a 8.39% decline from 2021.
  • Quest Diagnostics annual revenue for 2021 was $10.788B, a 14.32% increase from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$20.9B
DaVita (DVA)$12.1B
Encompass Health (EHC)$10.3B
Chemed (CHE)$8.3B
Elanco Animal Health (ELAN)$6.4B
RadNet (RDNT)$5.2B
Option Care Health (OPCH)$4B
Amedisys (AMED)$3.2B
Astrana Health (ASTH)$2.9B
LifeStance Health (LFST)$2.7B
Addus HomeCare (ADUS)$2.4B
U.S Physical Therapy (USPH)$1.5B
Pennant (PNTG)$1B
Aveanna Healthcare Holdings (AVAH)$929M
Atai Life Sciences (ATAI)$198M
Daxor (DXR)$47M
MEDIROM Healthcare Technologies (MRM)$15M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$13M
Ontrak (OTRK)$7M
IMAC Holdings (BACK)$1M